glp 1 asa GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become GLP-1 Medications – Community Education
Description
The long-acting GLP-1 receptor agonists segment dominated the market with the largest revenue share of 55.5% in 2024, driven by their superior efficacy in sustained weight loss, cardiovascular benefits, and the convenience of once-weekly dosing

I know that they serve both men and women, but I feel as though they are marketing mostly toward women

Kooij IA, Sahami S, Meijer SL, et al

Sleep If you're not sleeping enough, it disrupts multiple hormonal systems, including incretin signaling

You may benefit from maintenance if you: Live an active lifestyle but still struggle with appetite cues

Let alcohol dry, follow the medication guide, and do not reuse needles or single-use devices
